Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The Europe specialty generics market size reached US$ 18.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 30.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.76% during 2023-2028.
Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc.
Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don’t require expensive and time-consuming research and development procedures. Additionally, they also don’t incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on route of administration, indication and distribution channel.
Breakup by Region:
Italy
Germany
France
United Kingdom
Spain
Rest of Europe
Breakup by Route of Administration:
Injectables
Oral
Others
Breakup by Indication:
Oncology
Autoimmune Diseases
Infectious Diseases
Others
Breakup by Distribution Channel:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Competitive Landscape:
The leading players in the European specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the Europe specialty generics market in 2022?
2. What is the expected growth rate of the Europe specialty generics market during 2023-2028?
3. What are the key factors driving the Europe specialty generics market?
4. What has been the impact of COVID-19 on the Europe specialty generics market?
5. What is the breakup of the Europe specialty generics market based on the route of administration?
6. What is the breakup of the Europe specialty generics market based on the indication?
7. What is the breakup of the Europe specialty generics market based on the distribution channel?
8. What are the key regions in the Europe specialty generics market?
Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc.
Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don’t require expensive and time-consuming research and development procedures. Additionally, they also don’t incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on route of administration, indication and distribution channel.
Breakup by Region:
Italy
Germany
France
United Kingdom
Spain
Rest of Europe
Breakup by Route of Administration:
Injectables
Oral
Others
Breakup by Indication:
Oncology
Autoimmune Diseases
Infectious Diseases
Others
Breakup by Distribution Channel:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Competitive Landscape:
The leading players in the European specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the Europe specialty generics market in 2022?
2. What is the expected growth rate of the Europe specialty generics market during 2023-2028?
3. What are the key factors driving the Europe specialty generics market?
4. What has been the impact of COVID-19 on the Europe specialty generics market?
5. What is the breakup of the Europe specialty generics market based on the route of administration?
6. What is the breakup of the Europe specialty generics market based on the indication?
7. What is the breakup of the Europe specialty generics market based on the distribution channel?
8. What are the key regions in the Europe specialty generics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 EUROPE SPECIALTY GENERICS MARKET: INTRODUCTION
5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?
6 EUROPE SPECIALTY GENERICS MARKET
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 United Kingdom
10.3.1 Market Overview
10.3.2 Market Performance
10.4 Spain
10.4.1 Market Performance
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 EUROPE SPECIALTY GENERICS MARKET: INTRODUCTION
5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?
6 EUROPE SPECIALTY GENERICS MARKET
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY DISTRIBUTION CHANNEL
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 United Kingdom
10.3.1 Market Overview
10.3.2 Market Performance
10.4 Spain
10.4.1 Market Performance
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 Key Players
LIST OF TABLES
Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2023-2028
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2023-2028
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2023-2028
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2023-2028
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players
Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2023-2028
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2023-2028
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2023-2028
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2023-2028
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players
LIST OF FIGURES
Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2022
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2022
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2017 & 2022
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2017 & 2022
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2017 & 2022
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2017 & 2022
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2017 & 2022
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2017 & 2022
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2017 & 2022
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion US$), 2017 & 2022
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion US$), 2023-2028
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion US$), 2017 & 2022
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion US$), 2023-2028
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion US$), 2017 & 2022
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion US$), 2023-2028
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 34: France: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2022
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2022
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2017 & 2022
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2017 & 2022
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2017 & 2022
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2017 & 2022
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2017 & 2022
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2017 & 2022
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2017 & 2022
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2023-2028
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion US$), 2017 & 2022
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion US$), 2023-2028
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion US$), 2017 & 2022
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion US$), 2023-2028
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion US$), 2017 & 2022
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion US$), 2023-2028
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 34: France: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion US$), 2017 & 2022
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
